60 Degrees Pharmaceuticals, Inc. SXTP 深 沪
等待开盘 05-15 09:30:00 美东时间
1.46
-0.040
-2.67%
华盛通- 最 高1.50
- 今 开1.45
- 成交量 5.24万股
- 最 低 1.45
- 昨 收 1.50
- 总市值 384.97万
- 52周最高 14.68
- 市盈率 静 --
- 换手率 1.99%
- 52周最低 1.29
- 委 比 47.24%
- 总股本 263.68万
- 历史最高 2076.00
- 量 比 0.73
- 振 幅 3.33%
- 历史最低 1.36
- 每 手 1
- 风险率 2.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 小摩上调Lumentum控股目标价从565美元升至950美元；大小摩齐上调美国铝业目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13美元升至13.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8.25美元升至9美元
04-10 18:27
Ascendiant Capital Maintains Buy on 60 Degrees, Lowers Price Target to $4.2
Ascendiant Capital analyst Lucas Ward maintains 60 Degrees (NASDAQ:SXTP) with a Buy and lowers the price target from $11.2 to $4.2.
04-09 19:43
60 Degrees Pharmaceuticals shares are trading higher. The company reported its Q4 financial results.
60 Degrees Pharmaceuticals shares are trading higher. The company reported its ...
03-31 23:46
60 Degrees Q4 EPS $(1.47) Misses $(1.12) Estimate, Sales $303.385K Miss $400.000K Estimate
60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(1.47) per share which missed the analyst consensus estimate of $(1.12) by 31.25 percent. This is a 97.41 percent increase over losses of $(56.80) per share from the
03-31 19:50
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification With FDA For Australian Chestnut Extract; Inks Deal To License Florida State University's Ownership Rights To New Capsule Formulation Methods For Australian Chestnut Extract
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced it submitted a
03-18 20:10
What's Going On With 60 Degrees Pharmaceuticals On Friday?
60 Degrees Pharma shares fall premarket after a huge rally as its babesiosis trial reports a 100% cure rate with tafenoquine treatment.
03-13 21:11
60 Degrees Pharmaceuticals Says All Three Patients Cured Of Babesiosis After Tafenoquine Treatment In Expanded Use Clinical Trial
All three patients enrolled in study have been cured, confirming high cure rate of tafenoquine in immunosuppressed patients, as reported by Yale in a 2024 publicationCompany calls for existing babesiosis treatment
03-11 19:26
60 Degrees Pharma shares are trading lower. The company announced a partnership with GoodRx to offer eligible consumers savings of up to 30% on ARAKODA.
60 Degrees Pharma shares are trading lower. The company announced a partnership...
02-03 03:00
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
60 Degrees Pharmaceuticals shares are trading higher after the company announced a partnership with Runway Health to expand pre-departure access to ARAKODA.
60 Degrees Pharmaceuticals shares are trading higher after the company announce...
01-22 21:07
